Status:
COMPLETED
Blended Treatment för PTSD Feasibility Study
Lead Sponsor:
Karolinska Institutet
Conditions:
Acceptability of Health Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Feasibility and pilot study using within-group design with the aim of examining whether the blended psychological treatment for PTSD is acceptable for patients and therapists. 20 patients will be incl...
Detailed Description
Research question and hypothesis The research question is: Is blended psychological treatment for PTSD via a digital support acceptable and applicable to patients and clinicians? The hypothesis is th...
Eligibility Criteria
Inclusion
- PTSD according to DSM-5 criteria (American Psychiatric Association, 2013) as a primary problem
- have basic knowledge of speaking and writing in Swedish,
- not undergo other psychological treatment for PTSD during the course of the study;
- be at least 18 years old
- not be exposed to ongoing violence or threats
- if antidepressants for depression / anxiety are available, the dose must have been stable for at least 6 weeks before starting treatment.
- Patients who express an interest in participating receive information about the study. Patients who subsequently carry out the assessment and meet the inclusion criteria receive accurate oral and written information about what participation includes and handling of personal data and data. If the patient wants to participate and gives written consent, the person is included in the study.
Exclusion
- \-
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04881643
Start Date
May 20 2021
End Date
July 3 2023
Last Update
March 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Sweden